Clinical Trial Detail

NCT ID NCT02399813
Title Phase 2 Study of ADXS11-001 in Subjects With Anal Cancer or Cancer of the Rectum
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Advaxis, Inc.
Indications

anal canal cancer

rectum cancer

Therapies

ADXS11-001

Age Groups: adult

No variant requirements are available.